Completed

Phase 2
Age: 21Years - 45Years
FEMALE
ID00000295

Progesterone Treatment in Female Smokers

Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

N

National Institute on Drug Abuse (NIDA)

Lead Sponsor

U

University of Minnesota

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to investigate progesterone effects in female smokers

CONDITIONS

Official Title

Progesterone Treatment in Female Smokers - 12

Who Can Participate

Age: 21Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

Female subjects aged 21-45 years with a smoking history of at least 20 cigarettes daily for at least 1 year. In good health as verified by medical history, screening examination, and screening laboratory tests. Not pregnant as determined by pregnancy screening nor breast feeding, and using acceptable birth control methods other than hormonal contraceptives.

Not Eligible

You will not qualify if you...

History of heart disease, peripheral vascular disease, COPD, liver diseases, abnormal vaginal bleeding, suspected or known breast malignancy, or any other medical condition which physician investigator deems inappropriate for subject participation. Use of regular psychotropic medication (antidepressants, antipsychotics, or anxiolytics) and recent psychiatric history. Amenorrhea. Current use of oral or other types of hormonal contraceptives. Abuse of alcohol or any other recreational or prescription drug. Regular use of any other tobacco products, including smokeless tobacco and nicotine products. Known allergy to progesterone or peanuts.

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

N/A

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

0

Similar Trials

5-HT2A Agonist Psilocybin for Treating Tobacco Use Disorder ...

Tobacco Use Disorder

Actively Recruiting

3 locations

Accelerated Deep Transcranial Magnetic Stimulation for Smoki...

Tobacco Use Disorder

Actively Recruiting

2 locations

An fMRI Study of Clavulanic Acid Effects on Tobacco Use Diso...

Tobacco Use Disorder

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here